Published May 28, 2020 | Version v1
Patent Open

USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION

  • 1. University of Chicago
  • 2. Salix Pharmaceuticals

Contributors

Description

Presented herein are methods for preventing or treating tumor growth, tumor metastasis and/or abnormal proliferation of tumor cells in a subject, wherein the methods involve administration of a pharmaceutical composition comprising methylnaltrexone. Also presented herein are methods for inhibiting or slowing the growth of a tumor in a subject, wherein the methods include selecting a subject who is a suitable candidate for treatment with methylnaltrexone, and administering a composition comprising methylnaltrexone to the subject.

Files

US20200163958.pdf

Files (3.2 MB)

Name Size Download all
md5:a0223903715c6b0ccf369758ac28bbd6
3.2 MB Preview Download

Additional details

Identifiers

Patent application number
US 201916667300 A
Patent number
US 2020/0163958 A1
Other
oai:uchicago.tind.io:9483

Dates

Patent filed
2019-10-29

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Anesthesia and Critical Care